To clarify the target of RAS in osteoporosis after gut microbiota dysbiosis, we treated losartan (AT1R inhibitor), PD123319 (AT2R inhibitor), and CGP42112A (AT2R agonist) for 4 weeks after the diagnosis of osteoporosis (Figure 4A). This evidence concerns the gene AGTR1 and osteoporosis.